New program aims to improve dental care in schizophrenia patients

NCT ID NCT02512367

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a dental health education program for people with schizophrenia to see if it could improve their oral hygiene and quality of life. Participants were randomly assigned to either the education program or standard monitoring. The study lasted 12 months and included dental check-ups at the start, 6 months, and 12 months. Unfortunately, the trial was terminated early, so the results are limited.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Dental care education program
What this could lead to
If successful, this program could help people with schizophrenia maintain better dental health and improve their overall well-being.
What could go wrong
The trial was terminated early with only 79 participants, so results are limited and may not be reliable. The program may not work for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SCHIZOPHRENIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CH Esquirol

    Limoges, 87025, France

  • CH La Chartreuse

    Dijon, 21000, France

  • CH Le Vinatier

    Bron, 69678, France

  • CH de Jury

    Metz, 57073, France

  • CH de Novillars

    Novillars, 25220, France

  • CH de Saint-Rémy et Nord Franche Comté

    Saint-Rémy, 70160, France

  • CH de Semur en Auxois

    Semur-en-Auxois, 21140, France

  • CHS de la Savoie

    Chambéry, 73011, France

  • CHS du Jura

    Dole, 39108, France

  • CHU de Besançon

    Besançon, 25000, France

  • CHU de DIJON

    Dijon, 21079, France

  • Chs Epsan

    Brumath, 67173, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.